Home  > Plants > Julphar - XI

 

Julphar - XI

Human Insulin Plant

 

 

  Julphar XI  
 

Human Insulin Plant

The new Insulin manufacturing facility in Ras Al Khaimah is one of the most modern biotechnological plants designed for producing recombinant human insulin crystals. The plant is being built in accordance with the latest EMEA* regulations utilizing the best available technologies in the market to comply with the latest international quality standards.

 

* European Medicines Agency 

 

 

CAPABILITIES & INVESTMENT

 

 

PRODUCTION CAPACITY

 

 

HUMAN CAPABILITIES

 

 

FINANCIAL INVESTMENT

Julphar Insulin Plant fermentation facilities are designed to produce 450 batches of 10,000L fermentation broth per year, yielding 1,500kg of insulin crystals, which will enable us to produce more than 40 million vials of insulin.

 

 

Julphar Insulin Plant is operated by more than 120 experienced team of biotechnologists and engineers, who are highly skilled and dedicated in providing the highest assurance and satisfaction to our clients in project management, production, logistics and quality.

 

 

To augment Julphar Insulin plant facility, which is one of the biggest biotechnology plants in the Middle East, Julphar has invested approximately Dhs550 million (US$150 million).

 

Read More

 

 
     

 

   

Go up

   

Print this page